The health minister's office says steps are being taken to address Canada's drug shortages and to strengthen its drug capacity, but the Pharmaceutical and Life Sciences Sciences Sector Task Force's report says Ottawa's pharmaceutical policies have eroded domestic and foreign direct investment, exacerbated by global trade dynamics and pricing policy rebalancing.